PharmaTalkRadio

This podcast features a panel discussion on desgining and developing drug delivery and devices for LMICs with representatives from Gilead Sciences, the Bill & Melinda Gates Foundation, ApiJect and AbbVie From the 2024 PODD: Partnership Opportunities in Drug Delivery.

The panelists discuss unique and compelling challenges of the last mile for LMICs, the role of pharma and medtech in the evolution of LMIC drug development, trends in the space, case studies of successful products and how to better consider cultural differences between LMICs and more developed markets.

To learn more about the PODD conference, please visit PODDConference.com.

For more information, go to CRAACOevent.com or realtime-eclinical.com

For more information, visit theconferenceforum.org

For more information, visit theconferenceforum.org.

For more information, visit theconferenceforum.org

For more information, visit theconferenceforum.org

For more information, go to theconferenceforum.org

As viruses evolve to resist vaccines and therapeutics, new targeted approaches to deliver broad-spectrum antivirals are needed.

In this podcast, Anil Diwan, President and Executive Chairman of NanoViricides Incorporated, explains some of the shortcomings of the current model of antiviral drug development and how NanoViricides developed a nanotechnology with a different approach to develop and deliver antiviral drugs. Anil also presents an overview of the scientific and clinical development of NanoViricides lead program, NV-387 as well as potential applications in different indications. 

For more information about NanoViricides Incorporated, visit NanoViricides.com. 

For more information about the annual  PODD drug delivery conference, please visit Drug-Delivery.org.

For more information, visit theconferenceforum.org

For more information, visit theconferenceforum.org